Medical Park Pharmacy Recalls Lidocaine/Prilocaine Cream Due to Expired Components
MPRX, Inc. dba Medical Park Pharmacy is recalling Lidocaine/Prilocaine/PE cream compounded with expired components and incorrect labeling.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error and use of expired components, which aligns with the rubric for moderate severity involving minor labeling errors or low-risk contamination.
Plain-English summary
MPRX, Inc. dba Medical Park Pharmacy is voluntarily recalling 12 jars of Lidocaine/Prilocaine/PE 30/5/0.25% 30 GM cream. The recall was initiated because the products were compounded using expired components and had incorrect or missing lot and expiration date labeling.
The affected product is distributed in Texas. Specific lots involved include 61134:42 (Use by: 01/31/2020), 61302:26 (Use by: 04/14/2020), and 61318:42 (Use by: 04/19/2020).
Consumers who have this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars
- Manufacturer
- MPRX, Inc. dba Medical Park Pharmacy
- Category
- Drug — Topical Anesthetic
- Affected units
- 12
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 61134:42 Use by: 01/31/2020
- 61302:26 Use by: 04/14/2020
- 61318:42 Use by: 04/19/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 18 recalled by MPRX, Inc. dba Medical Park Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · MPRX, Inc. dba Medical Park Pharmacy
See all →- ModerateProgesterone 50 mg Capsules Recalled for Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Naltrexone Capsules Due to Labeling Errors
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Lidocaine/Prilocaine Cream Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Finasteride/Biotin Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Liothyronine Due to Expired Components
FDA (Drugs) · 2020-02-05
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAkorn Recalls Lidocaine and Prilocaine Cream Due to Impurity
FDA (Drugs) · 2018-08-15
- ModerateLidocaine-Prilocaine Cream Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- ModerateReliable Drug Recalls Lidocaine, Tetracaine, and Benzocaine Compounded Products
FDA (Drugs) · 2016-07-13
- ModeratePrilocaine HCl USP Recalled for Lack of Stability Data
FDA (Drugs) · 2018-02-28
- ModerateLidocaine USP Recalled Due to Missing Stability Data
FDA (Drugs) · 2018-02-28
- SeverePark Compounding Pharmacy Recalls Prostaglandin PGE-1 Due to Sterility Concerns
FDA (Drugs) · 2015-11-04